metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Metaplasia intestinal en la unión esofagogástrica. Prevalencia y asociaciones ...
Journal Information
Vol. 25. Issue 8.
Pages 487-492 (January 2002)
Share
Share
Download PDF
More article options
Vol. 25. Issue 8.
Pages 487-492 (January 2002)
Full text access
Metaplasia intestinal en la unión esofagogástrica. Prevalencia y asociaciones en una población sometida a endoscopia
Intestinal metaplasia at the esophagogastric junction. prevalence and association in patients undergoing endoscopy
Visits
8636
M.L. de Castro
,c
, C. Fachala, J.R. Pinedad, F. Domínguezd, J.I.R. Pradab, J.A. Hermod, J. Susoc, J. Clofentd
a Servicios de Aparato Digestivo, Anatomía Patológica Hospital Meixoeiro. España
b Servicios de Aparato Digestivo, Unidad de Investigación. Hospital Meixoeiro. España
c Servicio de Aparato Digestivo. Hospital Xeral-Cíes. Vigo. España
d Servicios de Aparato Digestivo, Hospital Meixoeiro
This item has received
Article information
Objetivo

La metaplasia intestinal (MI) de segmento corto en la unión gastroesofágica es una entidad muy controvertida. Diversos estudios han comunicado amplias variaciones en su prevalencia y en los factores asociados con su desarrollo. Recientemente se diferencia entre MI esofágica y MI cardial, asumiendo una etiopatogenia y un pronóstico diferentes. Pretendemos estudiar la prevalencia de esta entidad en nuestro medio y su asociación con la enfermedad por reflujo gastroesofágico (ERGE) y con la infección por Helicobacter pylori.

Métodos

En 161 pacientes se obtuvieron biopsias en el esófago distal (2), bajo la línea Z (3) y en el antro gástrico (3) y se midieron las distancias desde los incisivos a la línea Z (ILZ) y a la unión gastroesofágica (IEG). La presencia de células caliciformes positivas con azul alcian-PAS fue diagnóstica de MI, clasificándose como MI esofágica si ILZ < IEG o MI cardial ante la coincidencia entre ambas medidas. La detección de H. pylori se realizó mediante test de ureasa (CLO-test) e histología. Consideramos ERGE ante la presencia de síntomas típicos o lesiones endoscópicas e histológicas en esófago distal. En 54 pacientes con MI (73%) se realizaron manometría y pH-metría de 24 h.

Resultados

Presentaban MI 74 pacientes (46%), correspondiendo a 33 sujetos con metaplasia esofágica (20,5%) y 41 casos de metaplasia cardial (25,4%). La presencia de MI en la unión gastroesofágica se asoció con la edad (p = 0,007) y a la toma de inhibidores de la bomba de protones (p = 0,004). No encontramos ninguna relación entre la ERGE (clínica, endoscópica o histológica) y la presencia de MI esofágica o cardial. La infección por H. pylori no se asoció con la presencia de MI en el cardias, aunque sí con una menor frecuencia de lesiones esofágicas por reflujo. La pH-metría ORIGINALES de 24 h no detectó diferencias en la exposición ácida entre los pacientes con MI esofágica o cardial.

Conclusiones

La existencia de segmentos cortos de metaplasia intestinal en la unión esofagogástrica es frecuente en la población sometida a endoscopia, y su relación con la edad sugiere un origen adquirido para esta lesión. No encontramos ninguna asociación entre MI esofágica y ERGE, evaluada mediante clínica, endoscopia, histología o cuantificación del pH intraesofágico. La infección por H. pylori no se asoció con la presencia de MI cardial.

Aim

Short segments of intestinal metaplasia (IM) at the esophagogastric junction is an unclear entity. Several studies have reported wide variations in its prevalence and in the factors associated with its development. Recently, this entity has been divided into esophageal IM and cardiac IM, as two different lesions in etiopathogenesis and prognosis. We studied the prevalence of these conditions and their association with gastroesophageal reflux disease (GERD) and Helicobacter pylori infection.

Methods

In 161 patients, biopsies were obtained from the distal esophagus (2), just below the Z line (3), and in the gastric antrum (4). IM was diagnosed on the basis of staining of goblet cells with Alcian blue and was classified as esophageal if ILZ < IEG or cardiac ILZ = IEG. H. pylori was determined by rapid urease (CLO-test) and histology. Diagnosis of GERD was based on typical symptoms, endoscopy, and histology. In 54 patients with IM (73%) esophageal manometry and 24-hour pH-metry was also performed.

Results

IM was detected in 74 patients (46%); IM was esophageal in 33 patients (20.5%) and cardiac in 41 patients (25.4%). Patients with IM were significantly older than those without (p = 0.007) and took proton pump inhibitors more frequently (p = 0.004). No correlation was found between reflux symptoms, esophageal lesions or histologicalchanges with either type of IM. No differences between esophageal or cardiac IM were detected by esophageal pH-metry. H. pylori infection was unrelated to cardiac IM, but these patients had a lower frequency of endoscopic and histological changes in the distal esophagus.

Conclusions

Intestinal metaplasia is a common finding in patients sent for gastroscopy and is probably an acquired lesion that increases in prevalence with age. We found no associations between esophageal IM and GERD, evaluated by typical symptoms, endoscopic and histological changes and pHmetry. H. pylori infection showed no relation to cardiac IM.

Full text is only aviable in PDF
Bibliografía
[1.]
M. Pera, A.J. Cameron, V.F. Trastek, H.A. Carpenter, A.R. Zinsmeister.
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction.
Gastroenterology, 104 (1993), pp. 510-513
[2.]
W.C. Mac Donald, J.B. Mac Donald.
Adenocarcinoma of the esophagus and/or gastric cardia.
Cancer, 60 (1987), pp. 1094-1098
[3.]
R.A. Parenti, G. Zaninotto, S. Merigliano, M. Costantini, M. Cagol, R. Alfieri, et al.
Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia.
Cancer, 88 (2000), pp. 2520-2528
[4.]
S.J. Spechler, J.M. Zeroogian, D.A. Antonioli, H.H. Wang, R.K. Goyal.
Prevalence of metaplasia at the gastro-esophageal junction.
Lancet, 344 (1994), pp. 1533-1536
[5.]
A.P. Weston, P. Krmpotich, W.F. Makdisi, R. Cherian, A. Dixon, D.H. McGregor, et al.
Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings and association with gastric intestinal metaplasia.
Am J Gastroenterol, 91 (1996), pp. 981-986
[6.]
M.H. Johnston, A.S. Hammond, W. Laskin, M. Jones.
The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy.
Am J Gastroenterol, 91 (1997), pp. 1507-1511
[7.]
S. Nandukar, C.J. Talley, T.H. Martin, S. Adams.
Short segment Barrett's oesophagus: prevalence, diagnosis and associations.
Gut, 40 (1997), pp. 710-715
[8.]
T.G. Morales, R.E. Sampliner, A. Bhattacharyya.
Intestinal metaplasia of the gastric cardia.
Am J Gastroenterol, 92 (1997), pp. 414-418
[9.]
N.J. Trudgill, S.K. Suvarna, K.C. Kapur, S.A. Riley.
Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy.
Gut, 41 (1997), pp. 585-589
[10.]
S.J. Spechler, R.K. Goyal.
The columnar-lined esophagus, intestinal metaplasia and Norman Barrett.
Gastroenterology, 110 (1996), pp. 614-621
[11.]
P. Sharma, T.G. Morales, R.E. Sampliner.
Shot segment Barrett's esophagus. The need for standardization of the definition and of endoscopic criteria.
Am J Gastroenterol, 93 (1998), pp. 1033-1036
[12.]
A. Dias Pereira, A. Suspiro, P. Chaves, A. Saraiva, L. Gloria, J.C. Mendes de Almeida, et al.
Short segments of Barrett's epithelium and intestinal metaplasia in normal appearing oesophagogastric junctions: the same or two different entities.
Gut, 42 (1998), pp. 659-662
[13.]
G.R. Locke, N.J. Talley, S.L. Fett, A.R. Zinsmeister, L.J. Melton.
Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmsted County, Minnesota.
Gastroenterology, 112 (1997), pp. 1448-1456
[14.]
M. Savary, G. Miller.
L'oesophague. Manual et atlas d'endoscopie.
[15.]
F.G. De Nardi, R.H. Riddell.
The normal esophagus.
Am J Surg Pathol, 15 (1991), pp. 296-309
[16.]
W.M. Weinstein, A.F. Ippoliti.
The diagnosis of Barrett's esophagus: goblets, goblets, goblets.
Gastrointest Endosc, 44 (1996), pp. 91-94
[17.]
R.C. Haggitt.
Barrett's esophagus, dysplasia and adenocarcinoma.
Hum Pathol, 25 (1994), pp. 982-992
[18.]
S.K. Heier, F. Seif, S. Webber, N. Bannan, S. Khan, A. Pathapati, et al.
Short segment Barrett's esophagus: clinical,and histologic findings.
Gastroenterology, 110 (1994), pp. A132
[19.]
M. Voutilainen, M. Färkkilá, M. Juhola, K. Nuorva, K. Mauranen, T. Mäntynen, et al.
Specialised columnar epithelium of the esophagogastric junction: prevalence and associations.
Am J Gastroenterol, 94 (1999), pp. 913-917
[20.]
E.J. Kuipers, L. Lundell, E.C. Klinkenberg'Knol, N. Havu, H. Festen, Liedman, et al.
Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazol or fundoplication.
N Engl J Med, 334 (1996), pp. 1018-1022
[21.]
G. Sachs.
Gastritis, Helicobacter pylori, and proton pump inhibitors.
Gastroenterology, 112 (1997), pp. 1033-1034
[22.]
J.P. Byrne, S. Bhatnagar, B. Hamid, G.R. Armstrong, S.E.A. Attwood.
Comparative study of intestinal metaplasia and mucin staining at the cardia and esophagogastric junction in 225 symptomatic patients presenting for diagnostic open-access gastroscopy.
Am J Gastroenterol, 94 (1999), pp. 98-103
[23.]
S. Nandukar, N. Talley.
Barrett's esophagus: the long and the short of it.
Am J Gastroenterol, 94 (1999), pp. 30-39
[24.]
S.J. Spechler.
The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction.
Gastroenterology, 117 (1999), pp. 218-228
[25.]
G.W.B. Clark, A.P. Ireland, J.H. Peters, P. Chandrasoma, T.R. De Meester, C.G. Bremner.
Short-Segment Barrett's esophagus: a prevalent complication of gastroesophageal reflux disease with malignant potential.
J Gastrointest Surg, 1 (1997), pp. 113-122
[26.]
T. Loughney, C.L. Maydonovitch, R.K. Wong.
Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus.
Am J Gastroenterol, 93 (1998), pp. 916-919
[27.]
A. Hackelsberger, T. Günter, V. Schultze, G. Manes, J.E. Domínguez-Muñoz, A. Roessner, et al.
Intestinal metaplasia at the gastrooesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?.
Gut, 43 (1998), pp. 17-21
[28.]
J.R. Goldblum, J.J. Vicari, G.W. Falk, T.W. Rice, R.M. Peek, K. Easley, et al.
Inflammation and intestinal metaplasia of the cardia: the role of gastroesophageal reflux and H. pylori infection.
Gastroenterology, 114 (1998), pp. 633-639
[29.]
M. Voutilainen, M. Färkkilá, M. Jukka-Pekka, M. Juhola, P. Sipponen.
Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease.
Am J Gastroenterol, 94 (1999), pp. 3175-3180
[30.]
W.K. Hirota, T.M. Loughney, D. Lazas, C.L. Maydonovitch, V. Rholl, R.K.H. Wong.
Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.
Gastroenterology, 116 (1999), pp. 277-285
[31.]
P. Sharma, T.G. Morales, A. Bhattacharyya, H.S. Garewal, R.E. Sampliner.
Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Am J Gastroenterol, 92 (1997), pp. 2012-2015
[32.]
S.L. Kim, J.M. Wo, J.G. Hunter, L.P. Davis, J.P. Waring.
The prevalence of intestinal metaplasia in patients with and without peptic strictures.
Am J Gastroenterol, 93 (1998), pp. 53-55
[33.]
N.E. Schindlbeck, C. Heinrich, A. König, A. Dendorfer, F. Pace, S.A. Múller-Lissner.
Optimal thresholds, sensitivity and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease.
Gastroenterology, 93 (1987), pp. 85-90
[34.]
J.N. Glickman, H. Wang, K.M. Das, R.K. Goyal, S.J. Spechler, D. Antoniolo, et al.
Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI.
Am J Surg Pathol, 25 (2001), pp. 87-94
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos